Form 4: Oracle Director Sells $13.5M in Shares Under 10b5-1 Plan

Oracle Director Jeffrey Berg sold 49,365 shares of common stock for approximately $13.5 million through pre-planned transactions.

Summary

• Jeffrey Berg, a Director of Oracle Corp (ORCL), reported the sale of 49,365 shares of common stock.
• The transactions occurred on October 28, 2025, and were executed under a Rule 10b5-1(c) plan.
• The sales were conducted in four separate blocks at weighted average prices ranging from $281.579 to $284.307 per share.
• The total value of the shares sold amounts to approximately $13,999,999.95.
• Following these transactions, Berg's indirect beneficial ownership through The Berg Family Trust decreased to 151,999 shares.
• An additional 5,000 shares are indirectly beneficially owned by his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a director selling shares can sometimes be viewed negatively, the explicit mention of a Rule 10b5-1 plan mitigates concerns that the sale is based on new, undisclosed negative information, making it a routine, pre-planned event.

Positives

• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not based on new material non-public information.

Negatives

• A director reducing their stake, even if pre-planned, decreases their direct financial alignment with the company's shareholders.

Future Outlook

NA

Industry Context

Insider transactions, particularly sales by directors, are routinely monitored by investors for insights into management's perspective on the company's future. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of future performance compared to unscheduled sales, as they are pre-arranged and not typically driven by immediate market conditions or new information.

Related Party Transactions

• Shares are indirectly owned by The Berg Family Trust and by spouse.

Stakeholder Impact

• Shareholders may note the reduction in a director's indirect ownership, but the pre-planned nature of the sale under a 10b5-1 plan suggests it is not a reaction to new company-specific information.

Key Dates

Recommendation

The filing reports a pre-planned insider sale by a director under a Rule 10b5-1 plan. Such transactions are generally considered routine and do not typically signal a significant change in the company's fundamental outlook. Therefore, this filing alone does not provide a strong basis for a 'buy' or 'sell' recommendation, leading to a 'hold' stance as it's not indicative of new, material information that would alter an investment thesis.

Keywords

Oracle, ORCL, Jeffrey Berg, Director, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction